Study Evaluating the Feasibility of an Adapted Physical Activity Program During the Hospitalization Phase in Cancer Patients Undergoing Treatment
- Disease/Condition
- Cancer
- Drug/Device/Intervention
- adapted physical activity program (APA Program)
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Centre Hospitalier Universitaire de Besancon
- Phase
- N/A
- Start date
- Mar 01, 2024
- End date
- Dec 01, 2024
- Enrollment
- 32 participants
Validate the feasibility of a supervised adapted physical activity (APA) program during the first 7 days of hospitalization in medical oncology for patients with cancer undergoing treatment
This is a non-randomized, non-controlled feasibility study which will take place at the
 Besançon University Hospital in the conventional hospitalization department.
 
 It will be carried out with patients hospitalized in the conventional hospitalization
 department of the medical oncology department of Besançon University Hospital.
 
 At entry, after presenting the study and obtaining non-opposition from patients, an initial
 assessment will be carried out before the APA program. This assessment will include an
 evaluation of physical parameters (measurements of body composition, functional capacities,
 autonomy in activities of daily living and muscular strength), as well as an evaluation of
 quality of life relating to health and motivation to practice physical activity.
 
 At the end of the initial assessment, an APA program supervised (individually and in a room)
 by an APA teacher will be offered to patients. The sessions will be offered daily to patients
 (maximum 5 times/week). They will last on average 20 minutes each depending on the fatigue,
 pain and fitness of the patients. The objectives pursued are mainly an improvement in
 functional independence and mobility.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06321744
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06321744 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Universitaire de Besancon and is currently Not yet recruiting. The study focuses on Cancer. Target enrollment is 32 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.